Details For Selected Brain Tumor Treatment

Sponsored By

Please Click On The Above Banner For More Details

Back to New Treatments List


		Treatment Name:		An Open-label, Dose Confirmation and Dosimetry Study of Interstitial 131I-chTNT-1/B MAB (COTARA) for the Treatment of Glioblastoma Multiforme (GBM) at 1st of 2nd Relapse

		Phase:		Phase 1

		Treatment ID#:		1625 NABTT 0404

		Age Group:		Adults Only

		Min Karnofsky Score:		60: Requires occasional assistance but is able to care for most of own needs

		Conditions:		Prior Surgery is Allowed Prior Radiation is Sometimes Allowed Prior Chemotherapy is Allowed Glioblastoma multiforme, focal disease, which is progressive or recurrent following treatment.

		Last Updated:		11/06/2005

		Tumor Types:		Glioblastoma Multiforme


		Comments:		Patients who have received local therapy such as any of the following will be ineligible: radiosurgery, Brachytherapy, Gliadel wafers, other local therapy such as immunotherapy, or therapy with biologic agents including immunotoxins, immunoconjugates, antiangiogenesis compounds, antisense, peptide receptor antagonists, interferons, interleukins, TIL, LAD, or gene therapy.

		Treatment Type:		Radiation

		Contact:		Joy Fisher MA, CCRP Manager NABTT CNS Consortium John Hopkins, Bunting and Blaustein CRB 1650 Orleans Street, G87 Baltimore, MD 21231-1000 USA Phone: 410.955.3657 Fax: 410.614.9335 E-mail: jfisher@jhmi.edu Website: www.nabtt.org

Last updated refers to the date when our listing for each treatment was last updated.
ID is a combination of our internal ID and the official ID for the trial, if any.
Min Karnofsky is a general guide to how well you have to function to use this treatment

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By